Market Cap (In USD)
29.99 Thousand
Revenue (In USD)
1.36 Million
Net Income (In USD)
-14.42 Million
Avg. Volume
1153.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.0E-4-0.0407
- PE
- -
- EPS
- -
- Beta Value
- 6.525
- ISIN
- US00826A1097
- CUSIP
- 00826A109
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jonathan M. Couchman
- Employee Count
- -
- Website
- https://www.affymax.com
- Ipo Date
- 2006-12-15
- Details
- Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
More Stocks
-
ROVRRover Metals Corp.
ROVR
-
RMGGFResolute Mining Limited
RMGGF
-
AGESYageas SA/NV
AGESY
-
8061Seika Corporation
8061
-
WHN
-
MODIRUBBERModi Rubber Limited
MODIRUBBER
-
SPRY
-
MAP